Cardiol Therapeutics Inc. Class ACRDL
13F holders, Q1 2026 (March 31)At the end of Q1 2026, 47 institutions reported holding Cardiol Therapeutics Inc. Class A (CRDL) in their 13F filings, up 6 from Q4 2025. 15 opened new positions and 8 sold out. The largest holders were MMCAP International Inc. SPC ($20.7M), Tejara Capital Ltd ($6.9M) and Ikarian Capital, LLC ($3.7M). 2 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Cardiol Therapeutics Inc. Class A
- CUSIP
- 14161Y200
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 15 | $6.5M |
| Exits | 8 | $1.1M |
All 13F filers, Q4 2025 → Q1 2026: 20,210,175 shares bought and 1,417,023 shares sold, net +18,793,152 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 47 holders
| MMCAP International Inc. SPC | 1.81% | Add +7247.4% | 15,352,317 | $20.7M |
| Tejara Capital Ltd | 2.28% | No change | 5,130,122 | $6.9M |
| Ikarian Capital, LLC | 0.53% | New | 2,725,000 | $3.7M |
| Citadel Advisors | 0.00% | New | 819,904 | $1.1M |
| Boothbay Fund Management, LLC | 0.03% | New | 794,881 | $1.1M |
| Two Sigma Investments, LP | 0.00% | Add +31.3% | 534,211 | $721K |
| Integrity Alliance, Llc. | 0.02% | Add +6.9% | 465,025 | $630K |
| Goldman Sachs Group Inc. | 0.00% | Add +1.2% | 332,400 | $449K |
| Morgan Stanley | 0.00% | Reduce -27.3% | 250,421 | $338K |
| Renaissance Technologies | 0.00% | New | 229,806 | $310K |
| Jane Street Group, LLC | 0.00% | Add +218.8% | 126,957 | $172K |
| Summit Financial, LLC | 0.00% | No change | 104,059 | $140K |
| Knoll Capital Management, LLC | 0.07% | No change | 100,000 | $135K |
| Mgo One Seven LLC | 0.00% | No change | 100,000 | $135K |
| 1832 Asset Management L.P. | 0.00% | No change | 100,000 | $135K |
| PVG Asset Management Corp. | 0.07% | Add +10.3% | 107,165 | $113K |
| Susquehanna International Group, LLP | 0.00% | Reduce -65.5% | 70,396 | $95K |
| Geode Capital Management, LLC | 0.00% | No change | 52,435 | $71K |
| Quadrature Capital Ltd | 0.00% | New | 47,887 | $65K |
| JPMorgan Chase & Co. | 0.00% | New | 48,077 | $59K |
| Marble Harbor Investment Counsel, LLC | 0.01% | No change | 39,900 | $54K |
| Security National Bank of Sioux City Iowa | 0.03% | No change | 33,000 | $45K |
| Kovack Advisors, Inc. | 0.00% | New | 30,000 | $42K |
| Virtu Financial LLC | 0.00% | New | 23,917 | $32K |
| Boyer Financial Services, Inc. | 0.03% | Reduce -30.2% | 23,100 | $31K |
| Mercer Global Advisors Inc. | 0.00% | No change | 22,600 | $31K |
| Royal Bank of Canada | 0.00% | Add +62.3% | 21,648 | $29K |
| Jones Financial Companies LLLP | 0.00% | No change | 19,847 | $25K |
| Scientech Research LLC | 0.02% | New | 15,178 | $20K |
| Wealthspire Advisors, LLC | 0.00% | No change | 15,151 | $20K |
| Moneco Advisors, LLC | 0.00% | No change | 15,000 | $20K |
| Boomfish Wealth Group, LLC | 0.01% | New | 14,423 | $19K |
| Eaton Financial Holdings Company, LLC | 0.01% | New | 14,000 | $19K |
| Commonwealth Equity Services, LLC | 0.00% | Add +3.5% | 11,100 | $15K |
| Impact Partnership Wealth, LLC | 0.00% | No change | 10,850 | $15K |
| Advisory Services Network, LLC | 0.00% | New | 10,000 | $14K |
| Independent Advisor Alliance | 0.00% | No change | 10,000 | $14K |
| BNP Paribas Financial Markets | 0.00% | New | 10,000 | $14K |
| UBS Group AG | 0.00% | Reduce -48.0% | 8,609 | $12K |
| Piscataqua Savings Bank | 0.01% | No change | 5,000 | $10K |
| Baader Bank Aktiengesellschaft | 0.00% | New | 15,932 | $10K |
| TD Waterhouse Canada Inc. | 0.00% | Reduce -4.2% | 6,900 | $9K |
| Valley National Advisers Inc. | 0.00% | No change | 5,000 | $6K |
| National Bank of Canada | 0.00% | Add +36.6% | 2,323 | $3K |
| Osaic Holdings, Inc. | 0.00% | Reduce -27.2% | 500 | $675 |
| SBI Securities Co., Ltd. | 0.00% | No change | 475 | $641 |
| Barclays PLC | 0.00% | New | 200 | $270 |
"% of holder's portfolio" is CRDL's weight in each manager's 13F, not the share of Cardiol Therapeutics Inc. Class A the manager owns.